Nabriva Therapeutics Stock Forecast - Relative Strength Index

NBRVDelisted Stock  USD 1.62  0.01  0.61%   
Nabriva Stock Forecast is based on your current time horizon.
  
Nabriva Therapeutics AG has current Relative Strength Index of 51.87.
Check Nabriva Therapeutics VolatilityBacktest Nabriva TherapeuticsInformation Ratio  

Nabriva Therapeutics Trading Date Momentum

On December 04 2024 Nabriva Therapeutics AG was traded for  1.62  at the closing time. The top price for the day was 1.63  and the lowest listed price was  1.62 . There was no trading activity during the period 0.0. Lack of trading volume on December 4, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.62% .
Compare Nabriva Therapeutics to competition

Nabriva Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nabriva Therapeutics stock to make a market-neutral strategy. Peer analysis of Nabriva Therapeutics could also be used in its relative valuation, which is a method of valuing Nabriva Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Nabriva Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Nabriva Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nabriva Therapeutics shares will generate the highest return on investment. By undertsting and applying Nabriva Therapeutics stock market strength indicators, traders can identify Nabriva Therapeutics AG entry and exit signals to maximize returns.

Nabriva Therapeutics Risk Indicators

The analysis of Nabriva Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Nabriva Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nabriva stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Nabriva Stock

If you are still planning to invest in Nabriva Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nabriva Therapeutics' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies